Journal of Virology · 2018 · 25 citations · 57 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMolecular VirologyVaccinologyAntiviral ImmunityHumoral ImmunityImmune Responses To InfectionViral Immune EvasionViral InfectionsViral PathogenesisAdaptive Immune Responses To Viral InfectionAnti-viral ImmunityCellular Immune Response To VirusesCytomegalovirus DiseaseCytomegalovirus VaccinesHumoral Immunity ImpairmentT-cell Mediated ImmunityViral Immune Modulation
Rhesus cytomegalovirus (RhCMV) offers a unique model for studying human cytomegalovirus (HCMV) pathogenesis and vaccine development. RhCMV infection of nonhuman primates greatly broadened the understanding of mechanisms by which CMVs evade or reprogram T cell and natural killer cell responses in vivo . However, the role of humoral immunity and viral modulation of anti-CMV antibodies has not been studied in this model. There is evidence from in vitro studies that HCMVs can evade humoral immunity. By gene mapping and with the help of a novel cell-based reporter assay system we characterized the first RhCMV encoded IgG-Fcγ binding glycoprotein as a potent antagonist of rhesus FcγR activation. We further demonstrate that, unlike evasion of T cell immunity, this viral Fcγ receptor is not required to overcome anti-CMV immunity to establish secondary infections. These findings enable more detailed studies of the in vivo consequences of CMV evasion from IgG responses in nonhuman primate models.
57
Pierre Bruhns, Bruno Iannascoli, Patrick England et al. · Blood · 2008 · 1.5K citations · Full text
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen, Julia C. Ford, Matthew S. Lewis et al. · Nature · 2011 · 993 citations · Full text